Evidence map›Paper›PMID 31382848›Full record

Observational studyJournal of neurotrauma2021

Fibrinolytic Activation in Patients with Progressive Intracranial Hemorrhage after Traumatic Brain Injury.

Kelly A Fair, David H Farrell, Belinda H McCully, Elizabeth A Rick, Elizabeth N Dewey, Cole Hilliard, Rondi Dean, Amber Lin, Holly Hinson, Ronald Barbosa and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of neurotrauma, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. A dual-antibody sandwich immunoassay using upconversion nanoparticles and magnetic beads for fibrinogen detection.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Article
  9. Review
  10. The role of fibrinogen in traumatic brain injury: from molecular pathological mechanisms to clinical management.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Biomarkers in traumatic brain injury: new concepts.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kelly A FairOregon Health & Science University, Portland, Oregon, USA.
David H FarrellOregon Health & Science University, Portland, Oregon, USA.
Belinda H McCullyOregon Health & Science University, Portland, Oregon, USA.
Elizabeth A RickOregon Health & Science University, Portland, Oregon, USA.
Elizabeth N DeweyOregon Health & Science University, Portland, Oregon, USA.
Cole HilliardOregon Health & Science University, Portland, Oregon, USA.
Rondi DeanOregon Health & Science University, Portland, Oregon, USA.
Amber LinOregon Health & Science University, Portland, Oregon, USA.
Holly HinsonOregon Health & Science University, Portland, Oregon, USA.
Ronald BarbosaLegacy Emanuel Hospital and Health Center, Portland, Oregon, USA.
Martin A SchreiberOregon Health & Science University, Portland, Oregon, USA.
Susan E RowellOregon Health & Science University, Portland, Oregon, USA.

Funding

Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
Predictors of Low-risk Phenotypes after Traumatic Brain Injury Incorporating Proteomic Biomarker Signatures.K23NS110828 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HINSON, HOLLY ELAINE · 2020 to 2024
$1.0M
NCATS NIH HHS UL1 TR000128NINDS NIH HHS K23 NS110828
6 · The paper itself

Abstract

Progression of intracranial hemorrhage (PICH) is a significant cause of secondary brain injury in patients with traumatic brain injury (TBI). Previous studies have implicated a variety of mediators that contribute to PICH. We hypothesized that patients with PICH would display either a hypocoagulable state, hyperfibrinolysis, or both. We conducted a prospective study of adult trauma patients with isolated TBI. Blood was obtained for routine coagulation assays, platelet count, fibrinogen, thrombelastography, markers of thrombin generation, and markers of fibrinolysis at admission and 6, 12, 24, and 48 h. Univariate analyses were performed to compare baseline characteristics between groups. Linear regression models were created, adjusting for baseline differences, to determine the relationship between individual assays and PICH. One hundred forty-one patients met entry criteria, of whom 71 had hemorrhage progression. Patients with PICH had a higher Injury Severity Score and Abbreviated Injury Scale score (head), a lower Glasgow Coma Scale score, and lower plasma sodium on admission. Patients with PICH had higher D-dimers on admission. After adjusting for baseline differences, elevated D-dimers remained significantly associated with PICH compared to patients without PICH at admission. Hypocoagulation was not significantly associated with PICH in these patients. The association between PICH and elevated D-dimers early after injury suggests that fibrinolytic activation may contribute to PICH in patients with TBI.

Indexed as

Disease ProgressionAdultAgedBrain Injuries, TraumaticFemaleFibrinogenFibrinolysisGlasgow Coma ScaleHumansIntracranial HemorrhagesMaleMiddle AgedProspective StudiesThrombelastographyFibrinogencoagulopathyfibrinolysisthrombelastographytraumatic brain injury

Identifiers

PMID31382848
PMCPMC8054516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.